Results 301 to 310 of about 307,381 (359)

CD19: a promising target for systemic sclerosis

Kazuhiro Komura
openalex   +1 more source

Causal correlations between inflammatory proteins and heart failure: A two‐sample Mendelian randomization analysis

ESC Heart Failure, Volume 12, Issue 2, Page 1374-1385, April 2025.
Abstract Aims Inflammation plays a critical role in both the development and progression of heart failure (HF), which is a leading cause of morbidity and mortality worldwide. However, the causality between specific inflammation‐related proteins and HF risk remains unclear.
Xian‐Guan Zhu, Gui‐Qin Liu, Ya‐Ping Peng, Li‐Ling Zhang, Xian‐Jin Wang, Liang‐Chuan Chen, Yuan‐Xi Zheng, Xue‐Jun Xiang, Rui Qiao, Xian‐He Lin   +9 more
wiley   +1 more source

Insight from convergent validity of assessment of systemic sclerosis-associated Raynaud phenomenon with nailfold capillaroscopy. [PDF]

Rheumatol Adv Pract
Madathanapalli KA, Memon A, Nadella M, Shelton K, Zamani M, Makhijani A, Williams A, Gunes I, Kujawski SE, Odell W, Perez S, Page N, Duran Camacho L, Van Horn C, Wilson FP, Domsic R, Yu L, Pauling JD, Hinchcliff M.   +18 more
europepmc   +1 more source

Exercise haemodynamics in pulmonary hypertension – a prospective pressure–volume loop study on right ventricular adaptation and prognosis

European Journal of Heart Failure, EarlyView.
Multimodal assessment during exercise distinguishes clinically relevant right ventricular (RV) adaptation patterns (homeometric and heterometric adaptation) in pulmonary hypertension. Disease controls are patients with invasive exclusion of pulmonary hypertension.
Bruno R. Thal, Zvonimir A. Rako, Nils C. Kremer, Athiththan Yogeswaran, Patrick Janetzko, Selin Yildiz, Stephan Rosenkranz, Hossein Ardeschir Ghofrani, Werner Seeger, Friedrich Grimminger, Khodr Tello   +10 more
wiley   +1 more source

Cerebrovascular Involvement in Systemic Sclerosis. [PDF]

ACR Open Rheumatol
Cutolo M, Vojinovic T, Paolino S, Campitiello R, Smith V.   +4 more
europepmc   +1 more source

Pain and fatigue in systemic sclerosis: Practical strategies for non-pharmacological management. [PDF]

J Scleroderma Relat Disord
Bonomi F, El Aoufy K, Bellando Randone S, Matucci-Cerinic M, Hughes M.   +4 more
europepmc   +1 more source

Validation of the Turkish version of the assessment of systemic sclerosis-associated Raynaud's phenomenon (ASRAP). [PDF]

Turk J Med Sci
Temiz Karadağ D, Yilmaz Ş, Dikkanoğlu Demirok B, Pauling JD, Yazici A, Çefle A.   +5 more
europepmc   +1 more source

Emphysema elevates the DETECT scores: impact on pulmonary hypertension screening and diagnosis in systemic sclerosis. [PDF]

Rheumatology (Oxford)
Sauer GM, Käs F, Mihai CM, Elhai M, Dobrota R, Becker MO, Muraru S, Hoffmann-Vold AM, Distler O, Bruni C.   +9 more
europepmc   +1 more source

Anti-cytolethal distending toxin antibodies in systemic sclerosis: associations with gastrointestinal disease and immune dysregulation. [PDF]

Rheumatology (Oxford)
Di Ciommo FR, Casciola-Rosen L, Ayla AY, Balar A, Shah AA, Hughes M, Morales W, Pimentel M, Adler BL, McMahan ZH.   +9 more
europepmc   +1 more source

TGF-β1 promotes collagen synthesis in systemic sclerosis via upregulating P4HA3. [PDF]

J Transl Autoimmun
Chen Z, Lin Y, Huang Y, Chen Z, Gong Y, Hou Z, Lin L.   +6 more
europepmc   +1 more source